CBTRUS 统计报告：2014-2018 年美国儿童和青少年原发性脑及其他中枢神经系统肿瘤（基于儿科脑肿瘤基金会）。
CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.
机构信息
Central Brain Tumor Registry of the United States, Hinsdale, Illinois, USA.
Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina, USA.
出版信息
Neuro Oncol. 2022 Sep 6;24(Suppl 3):iii1-iii38. doi: 10.1093/neuonc/noac161.
Abstract
The CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018 comprehensively describes the current population-based incidence of primary malignant and non-malignant brain and other CNS tumors in children and adolescents ages 0-19 years, collected and reported by central cancer registries covering approximately 100% of the United States population. Overall, brain and other CNS tumors are the most common solid tumor, the most common cancer, and the most common cause of cancer death in children and adolescents ages 0-19 years. This report aims to serve as a useful resource for researchers, clinicians, patients, and families.
摘要
美国儿童脑肿瘤基金会的 CBTRUS 统计报告：2014-2018 年美国诊断的儿童和青少年原发性脑和其他中枢神经系统肿瘤全面描述了目前基于人群的 0-19 岁儿童和青少年原发性良恶性脑和其他中枢神经系统肿瘤的发病率，由中央癌症登记处收集和报告，覆盖了美国约 100%的人口。总体而言，脑和其他中枢神经系统肿瘤是儿童和青少年 0-19 岁中最常见的实体瘤、最常见的癌症和癌症死亡的主要原因。本报告旨在为研究人员、临床医生、患者和家属提供有用的资源。
相似文献
1
CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.
Neuro Oncol. 2022 Sep 6;24(Suppl 3):iii1-iii38. doi: 10.1093/neuonc/noac161.
2
Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011.
Neuro Oncol. 2015 Jan;16 Suppl 10(Suppl 10):x1-x36. doi: 10.1093/neuonc/nou327.
3
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.
Neuro Oncol. 2020 Oct 30;22(12 Suppl 2):iv1-iv96. doi: 10.1093/neuonc/noaa200.
4
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.
Neuro Oncol. 2019 Nov 1;21(Suppl 5):v1-v100. doi: 10.1093/neuonc/noz150.
5
CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020.
Neuro Oncol. 2024 May 6;26(Supplement_3):iii1-iii53. doi: 10.1093/neuonc/noae047.
6
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018.
Neuro Oncol. 2021 Oct 5;23(12 Suppl 2):iii1-iii105. doi: 10.1093/neuonc/noab200.
7
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2017-2021.
Neuro Oncol. 2024 Oct 6;26(Supplement_6):vi1-vi85. doi: 10.1093/neuonc/noae145.
8
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019.
Neuro Oncol. 2022 Oct 5;24(Suppl 5):v1-v95. doi: 10.1093/neuonc/noac202.
9
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.
Neuro Oncol. 2015 Oct;17 Suppl 4(Suppl 4):iv1-iv62. doi: 10.1093/neuonc/nov189. Epub 2015 Oct 27.
10
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020.
Neuro Oncol. 2023 Oct 4;25(12 Suppl 2):iv1-iv99. doi: 10.1093/neuonc/noad149.
引用本文的文献
1
Pediatric-Type Diffuse Low-Grade Gliomas: A Subgroup Defined by Peculiar Molecular Features and Distinct Prognostic Outcomes.
Cureus. 2025 Jul 23;17(7):e88575. doi: 10.7759/cureus.88575. eCollection 2025 Jul.
2
Illuminating radiogenomic signatures in pediatric-type diffuse gliomas: insights into molecular, clinical, and imaging correlations. Part I: high-grade group.
Radiol Med. 2025 Aug 25. doi: 10.1007/s11547-025-02078-9.
3
Recent Advances in the Therapeutic Potential of Cannabinoids Against Gliomas: A Systematic Review (2022-2025).
Pharmacol Res Perspect. 2025 Aug;13(4):e70160. doi: 10.1002/prp2.70160.
4
Summary of the collection on 'immunotherapy in pediatric brain tumors-an update'.
J Neurooncol. 2025 Aug 6. doi: 10.1007/s11060-025-05191-x.
5
Correlation Analysis of Imaging and Pathological Features of Ependymomas.
Int J Gen Med. 2025 Jul 21;18:4001-4009. doi: 10.2147/IJGM.S528992. eCollection 2025.
6
Old Tools in a New Era: The Continued Relevance of Chemotherapy in Pediatric Neuro-Oncology.
Curr Oncol. 2025 Jul 20;32(7):410. doi: 10.3390/curroncol32070410.
7
Recent advances in the study of reproductive function in pediatric patients with brain tumors.
Front Pediatr. 2025 Jul 10;13:1625359. doi: 10.3389/fped.2025.1625359. eCollection 2025.
8
The EIF4EBP1 gene encoding 4EBP1 is transcriptionally upregulated by MYC and linked to shorter survival in medulloblastoma.
Cell Death Discov. 2025 Jul 16;11(1):330. doi: 10.1038/s41420-025-02601-x.
9
Current Landscape of Preclinical Models for Pediatric Gliomas: Clinical Implications and Future Directions.
Cancers (Basel). 2025 Jul 2;17(13):2221. doi: 10.3390/cancers17132221.
10
Ultra-low-input cell-free DNA sequencing for tumor detection and characterization in a real-world pediatric brain tumor cohort.
Acta Neuropathol Commun. 2025 Jun 28;13(1):134. doi: 10.1186/s40478-025-02024-w.
本文引用的文献
1
Childhood cancer risks estimates following CT scans: an update of the French CT cohort study.
Eur Radiol. 2022 Aug;32(8):5491-5498. doi: 10.1007/s00330-022-08602-z. Epub 2022 Mar 1.
2
Wireless phone use in childhood and adolescence and neuroepithelial brain tumours: Results from the international MOBI-Kids study.
Environ Int. 2022 Feb;160:107069. doi: 10.1016/j.envint.2021.107069. Epub 2021 Dec 30.
3
Review of the risk of cancer following low and moderate doses of sparsely ionising radiation received in early life in groups with individually estimated doses.
Environ Int. 2022 Jan 15;159:106983. doi: 10.1016/j.envint.2021.106983. Epub 2021 Dec 24.
4
The risk of childhood brain tumors associated with delivery interventions: A Danish matched case-control study.
Cancer Epidemiol. 2022 Feb;76:102077. doi: 10.1016/j.canep.2021.102077. Epub 2021 Dec 2.
5
International trends in the incidence of brain tumours in children and young-adults and their association with indicators of economic development.
Cancer Epidemiol. 2021 Oct;74:102006. doi: 10.1016/j.canep.2021.102006. Epub 2021 Aug 19.
6
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
7
How much is too much? Systematic review of cumulative doses from radiological imaging and the risk of cancer in children and young adults.
Crit Rev Oncol Hematol. 2021 Apr;160:103292. doi: 10.1016/j.critrevonc.2021.103292. Epub 2021 Mar 2.
8
Pediatric Brain Tumors: Descriptive Epidemiology, Risk Factors, and Future Directions.
Cancer Epidemiol Biomarkers Prev. 2021 May;30(5):813-821. doi: 10.1158/1055-9965.EPI-20-1443. Epub 2021 Mar 2.
9
Genome-wide association study across pediatric central nervous system tumors implicates shared predisposition and points to 1q25.2 (PAPPA2) and 11p12 (LRRC4C) as novel candidate susceptibility loci.
Childs Nerv Syst. 2021 Mar;37(3):819-830. doi: 10.1007/s00381-020-04946-3. Epub 2020 Nov 23.
10
Genetic predisposition to longer telomere length and risk of childhood, adolescent and adult-onset ependymoma.
Acta Neuropathol Commun. 2020 Oct 28;8(1):173. doi: 10.1186/s40478-020-01038-w.
Zotero 插件